Related Experiment Videos
Infantile acropustulosis
Insights
Infantile acropustulosis is a rare, itchy rash mainly affecting Black male infants on their extremities. Dapsone is the only effective treatment for this condition, which typically resolves by age three.
Area of Science:
- Dermatology
- Pediatrics
Background:
- Infantile acropustulosis is an uncommon pustular dermatosis primarily affecting infants.
- The condition presents with recurrent, pruritic vesiculopustules on distal extremities.
Observation:
- Onset occurs from birth to 1 year, with spontaneous resolution between 2 and 3 years of age.
- Lesions are described as intensely pruritic, 1- to 3-mm vesiculopustules.
Findings:
- This condition predominantly affects Black male infants.
- Routine therapies are ineffective; dapsone has shown efficacy.
- Differential diagnosis is crucial due to overlapping features with other pediatric skin diseases.
Implications:
- Highlights the need for specific diagnosis and treatment of infantile acropustulosis.
- Emphasizes dapsone as a key therapeutic option.
- Informs pediatricians and dermatologists about this distinct entity for improved patient management.
Abstract:
A new case of infantile acropustulosis and a review of previous cases disclose an uncommon pustular dermatosis that occurs primarily in black male infants. This condition consists of intermittent and recurrent crops of intensely pruritic, 1- to 3-mm vesiculopustules that appear predominantly on distal extremities. The onset is from birth to 1 year of age, with spontaneous resolution occurring between the ages of 2 and 3 years. This eruption does not respond to routine therapies, and the only effective treatment has been dapsone. Because similar clinical features have been found in several other pediatric cutaneous diseases, we discuss the differential diagnosis.